All In Biotech

Drug Trial Radar · NCT02536079

NeuroAiD Safe Treatment Registry

Last checked: Nov 19, 2026Latest source record: Feb 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

2,000

Planned (sponsor's estimate)

Start

Jun 2014

Primary completion

Dec 2024

Study completion Dec 2025

Sponsor

Lead sponsor
CHIMES SocietyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Moleac Pte Ltd.
First posted
Aug 31, 2015

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The NeST registry is a pro-active industry-academic collaboration to assess the use and safety of NeuroAiD in the real world setting. An online entry system was set up to allow easy data entry and retrieval of clinical information.

Conditions

  • Brain Injury
  • NeuroAiD Use

Interventions

  • NeuroAiDDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients experiencing adverse eventsTime frame: 3 months

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • National Brain Center Hospital

    Jakarta, Indonesia · Recruiting

  • University Kebangsaan Malaysia Medical Centre

    Kuala Lumpur, Malaysia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.